| Identification | Back Directory | [Name]
3-Azetidinecarboxamide, 1-(aminosulfonyl)-N-(6-chloro-4-methoxy-3-pyridinyl)-3-[2-(1-methylethyl)phenyl]- | [CAS]
2569467-78-1 | [Synonyms]
ACT-1016-0707
3-Azetidinecarboxamide, 1-(aminosulfonyl)-N-(6-chloro-4-methoxy-3-pyridinyl)-3-[2-(1-methylethyl)phenyl]- | [Molecular Formula]
C19H23ClN4O4S | [MOL File]
2569467-78-1.mol | [Molecular Weight]
438.93 |
| Hazard Information | Back Directory | [Uses]
ACT-1016-0707 (Compound 49) is an orally active and selective LPA1 receptor antagonist. ACT-1016-0707 can be used for the research of fibrotic diseases[1]. | [References]
[1] Lescop C, et al. Discovery of the Novel, Orally Active, and Selective LPA1 Receptor Antagonist ACT-1016-0707 as a Preclinical Candidate for the Treatment of Fibrotic Diseases. J Med Chem. 2024 Feb 22;67(4):2397-2424. DOI:10.1021/acs.jmedchem.3c01827 |
|
|